Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation - PEACE-Peds

Study identifier:D525AL00001

ClinicalTrials.gov identifier:NCT01203904

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation for long term use in Pediatrics

Medical condition

Bronchial Asthma

Phase

N/A

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

301

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Sept 2010

Primary Completion Date: 01 Sept 2015

Study Completion Date: 01 Sept 2015

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jun 2016 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
Pulmicort	-

Documents available

CSR Synopsis
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information Center

1-877-240-9479

[email protected]

Investigators

Principal Investigator

Shigeru Yoshida

AstraZenecaKK